Biggest News Aggregation in the World
📰 Peripheral Access Kit News

Page 3 - Peripheral Access Kit News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Peripheral Access Kit. Real-time updates on events, politics, business and more.

Research Analysts' Weekly Ratings Changes for Silk Road Medical (SILK)

Several analysts have recently updated their ratings and price targets for Silk Road Medical (NASDAQ: SILK): 10/24/2023 – Silk Road Medical was upgraded by analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating. 10/11/2023 – Silk Road Medical was downgraded by analysts at Citigroup Inc. from a “buy” rating to a […]
United States Lucasw Buchanan Stifel Nicolaus Piper Sandler Kevinm Klemz Wasatch Advisors Inc

Piper Sandler Trims Silk Road Medical (NASDAQ:SILK) Target Price to $11.00

Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]
United States Lucasw Buchanan Piper Sandler Andrews Davis Advisornet Financial Inc Wells Fargo Company

Silk Road Medical, Inc (NASDAQ:SILK) Receives $37.60 Average Target Price from Brokerages

Silk Road Medical, Inc (NASDAQ:SILK – Get Free Report) has earned a consensus rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to […]
United States Andrews Davis Kevinm Klemz Stifel Nicolaus Wolfe Research Fred Alger Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Silk Road Medical (NASDAQ:SILK) versus Insulet (NASDAQ:PODD) Financial Contrast

Silk Road Medical (NASDAQ:SILK – Get Free Report) and Insulet (NASDAQ:PODD – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a summary of current […]
United States Insulet Corporation Silk Road Medical Get Free Report Road Medical Given Silk Road Medical

Q3 2023 Earnings Forecast for Silk Road Medical, Inc Issued By B. Riley (NASDAQ:SILK)

Silk Road Medical, Inc (NASDAQ:SILK – Free Report) – Research analysts at B. Riley raised their Q3 2023 earnings per share estimates for Silk Road Medical in a note issued to investors on Wednesday, August 2nd. B. Riley analyst N. Chatterji now expects that the company will earn ($0.35) per share for the quarter, up […]
United States Andrews Davis Piper Sandler Ericaj Rogers Stifel Nicolaus Ltd Zurich

Stifel Nicolaus Cuts Silk Road Medical (NASDAQ:SILK) Price Target to $45.00

Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Stifel Nicolaus from $50.00 to $45.00 in a research report report published on Wednesday morning, Marketbeat.com reports. They currently have a buy rating on the stock. A number of other equities research analysts also recently weighed in on SILK. Piper Sandler lowered […]
United States Stifel Nicolaus Andrews Davis Ericaj Rogers Piper Sandler Financial Services Group Inc

B. Riley Lowers Silk Road Medical (NASDAQ:SILK) Price Target to $54.00

Silk Road Medical (NASDAQ:SILK – Get Free Report) had its price target decreased by stock analysts at B. Riley from $58.00 to $54.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target would indicate a potential upside of 144.68% […]
United States Stifel Nicolaus Ericaj Rogers Financial Services Group Inc Wells Fargo Company Securities Exchange Commission

Silk Road Medical (NASDAQ:SILK) Given New $54.00 Price Target at B. Riley

Silk Road Medical (NASDAQ:SILK – Get Free Report) had its target price reduced by research analysts at B. Riley from $58.00 to $54.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target suggests a potential upside of 144.68% from the stock’s previous […]
United States Stifel Nicolaus Ericaj Rogers Wolfe Research Securities Exchange Commission Mengis Capital Management Inc
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science